[Reboxetine in the treatment of bulimia nervosa].
There is a substancial body of literature demonstrating the efficacy of selective serotonin reuptake inhibitors antidepressants (SSRI) in reducing binge eating and vomiting frequency in Bulimia Nervosa. Good therapeutic response to noradrenergic agents, like desipramine and reboxetine, though not frequently reported in literature, has already been demonstrated. This case report describes the treatment of Bulimia Nervosa with reboxetine (4 to 8 mg/day) and its favorable therapeutic results.
Castilho
Simone Mancini
SM
Instituto de Psiquiatria da Faculdade de Medicina da Universidade de São Paulo. São Paulo, SP, Brasil. simonemcastilho@hotmail.com
Costa
Luiz Henrique Viegas
LH
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002032:Bulimia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D000077593:Reboxetine
D000928:Antidepressive Agents; D009025:Morpholines; D000077593:Reboxetine
Reboxetina no tratamento da bulimia nervosa.